JCS/JHRS Guideline: Rivaroxaban Not Recommended for Patients With Nonvalvular Atrial Fibrillation and High Bleeding Risk - Reply.
作者信息
Ono Katsushige, Iwasaki Yu-Ki, Shimizu Wataru
机构信息
Department of Pathophysiology, Oita University School of Medicine.
Department of Cardiovascular Medicine, Nippon Medical School.
出版信息
Circ J. 2022 Jun 24;86(7):1205. doi: 10.1253/circj.CJ-22-0285. Epub 2022 May 27.
PMID:35644538
Abstract
摘要
Zotero 插件